Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Doublle Bioproducts is a specialized biotechnology company focused on the development and large-scale production of high-quality recombinant proteins and antibodies. Based in Guangzhou, China, the company serves as a critical supplier of raw materials for the life sciences industry, particularly for the manufacturing of cell and gene therapies. Their core product portfolio includes a wide range of GMP-grade cytokines such as IL-2, IL-15, and IL-21, which are essential for the activation and expansion of immune cells like CAR-T and NK cells. In addition to cytokines, they provide growth factors, monoclonal antibodies, and diagnostic reagents to global pharmaceutical companies and research institutions. The company is recognized for its rigorous quality management systems and its ability to support clinical-grade bioprocessing requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou DoublleBioproduct.